Literature DB >> 19906920

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Jun Chen1, Yuk Fai Lau, Elaine W Lamirande, Christopher D Paddock, Jeanine H Bartlett, Sherif R Zaki, Kanta Subbarao.   

Abstract

We characterized the cellular immune response to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in 12- to 14-month-old BALB/c mice, a model that mimics features of the human disease. Following intranasal administration, the virus replicated in the lungs, with peak titers on day 2 postinfection. Enhanced production of cytokines (tumor necrosis factor alpha [TNF-alpha] and interleukin-6 [IL-6]) and chemokines (CXCL10, CCL2, CCL3, and CCL5) correlated with migration of NK cells, macrophages, and plasmacytoid dendritic cells (pDC) into the lungs. By day 7, histopathologic evidence of pneumonitis was seen in the lungs when viral clearance occurred. At this time, a second wave of enhanced production of cytokines (TNF-alpha, IL-6, gamma interferon [IFN-gamma], IL-2, and IL-5), chemokines (CXCL9, CXCL10, CCL2, CCL3, and CCL5), and receptors (CXCR3, CCR2, and CCR5), was detected in the lungs, associated with an influx of T lymphocytes. Depletion of CD8(+) T cells at the time of infection did not affect viral replication or clearance. However, depletion of CD4(+) T cells resulted in an enhanced immune-mediated interstitial pneumonitis and delayed clearance of SARS-CoV from the lungs, which was associated with reduced neutralizing antibody and cytokine production and reduced pulmonary recruitment of lymphocytes. Innate defense mechanisms are able to control SARS-CoV infection in the absence of CD4(+) and CD8(+) T cells and antibodies. Our findings provide new insights into the pathogenesis of SARS, demonstrating the important role of CD4(+) but not CD8(+) T cells in primary SARS-CoV infection in this model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906920      PMCID: PMC2812346          DOI: 10.1128/JVI.01281-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

3.  Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.

Authors:  Yu-Ting Yen; Fang Liao; Cheng-Hsiang Hsiao; Chuan-Liang Kao; Yee-Chun Chen; Betty A Wu-Hsieh
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Constitutive expression of macrophage-inflammatory protein 2 (MIP-2) mRNA in bone marrow gives rise to peripheral neutrophils with preformed MIP-2 protein.

Authors:  S P Matzer; T Baumann; N W Lukacs; M Röllinghoff; H U Beuscher
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.

Authors:  Litao Yang; Hui Peng; Zhaoling Zhu; Gang Li; Zitong Huang; Zhixin Zhao; Richard A Koup; Robert T Bailer; Changyou Wu
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

6.  Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.

Authors:  Mark J Cameron; Longsi Ran; Luoling Xu; Ali Danesh; Jesus F Bermejo-Martin; Cheryl M Cameron; Matthew P Muller; Wayne L Gold; Susan E Richardson; Susan M Poutanen; Barbara M Willey; Mark E DeVries; Yuan Fang; Charit Seneviratne; Steven E Bosinger; Desmond Persad; Peter Wilkinson; Larry D Greller; Roland Somogyi; Atul Humar; Shaf Keshavjee; Marie Louie; Mark B Loeb; James Brunton; Allison J McGeer; David J Kelvin
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

7.  Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.

Authors:  Luisa Cervantes-Barragan; Roland Züst; Friedemann Weber; Martin Spiegel; Karl S Lang; Shizuo Akira; Volker Thiel; Burkhard Ludewig
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

8.  Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV).

Authors:  Leatrice N Vogel; Anjeanette Roberts; Christopher D Paddock; Gillian L Genrich; Elaine W Lamirande; Sagar U Kapadia; John K Rose; Sherif R Zaki; Kanta Subbarao
Journal:  Vaccine       Date:  2006-12-11       Impact factor: 3.641

9.  A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.

Authors:  Anjeanette Roberts; Damon Deming; Christopher D Paddock; Aaron Cheng; Boyd Yount; Leatrice Vogel; Brian D Herman; Tim Sheahan; Mark Heise; Gillian L Genrich; Sherif R Zaki; Ralph Baric; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

10.  Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.

Authors:  Jung-Yien Chien; Po-Ren Hsueh; Wern-Cherng Cheng; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

View more
  194 in total

1.  Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.

Authors:  Hsueh-Ling Janice Oh; Adeline Chia; Cynthia Xin Lei Chang; Hoe Nam Leong; Khoon Lin Ling; Gijsbert M Grotenbreg; Adam J Gehring; Yee Joo Tan; Antonio Bertoletti
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 2.  Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Authors:  Judy Chen; William J Kelley; Daniel R Goldstein
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

3.  Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

Authors:  John R Teijaro; David Verhoeven; Carly A Page; Damian Turner; Donna L Farber
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Authors:  Ji-Young Min; Leatrice Vogel; Yumiko Matsuoka; Bin Lu; David Swayne; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

5.  T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.

Authors:  Jincun Zhao; Jingxian Zhao; Stanley Perlman
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  [Analysis of the correlation between lymphocyte subsets and severity of corona virus disease 19].

Authors:  F Bao; W L Shi; J Hu; D Zhang; D H Gao; Y X Xia; H M Jing; X Y Ke; Q G Ge; N Shen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 7.  COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.

Authors:  Tanveer Ahmad; Rituparna Chaudhuri; Mohan C Joshi; Ahmad Almatroudi; Arshad Husain Rahmani; Syed Mansoor Ali
Journal:  Front Microbiol       Date:  2020-12-01       Impact factor: 5.640

8.  Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.

Authors:  Alessio Mazzoni; Lorenzo Salvati; Laura Maggi; Manuela Capone; Anna Vanni; Michele Spinicci; Jessica Mencarini; Roberto Caporale; Benedetta Peruzzi; Alberto Antonelli; Michele Trotta; Lorenzo Zammarchi; Luca Ciani; Leonardo Gori; Chiara Lazzeri; Andrea Matucci; Alessandra Vultaggio; Oliviero Rossi; Fabio Almerigogna; Paola Parronchi; Paolo Fontanari; Federico Lavorini; Adriano Peris; Gian Maria Rossolini; Alessandro Bartoloni; Sergio Romagnani; Francesco Liotta; Francesco Annunziato; Lorenzo Cosmi
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

9.  SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.

Authors:  Arne Sattler; Stefan Angermair; Helena Stockmann; Katrin Moira Heim; Dmytro Khadzhynov; Sascha Treskatsch; Fabian Halleck; Martin E Kreis; Katja Kotsch
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

10.  Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.

Authors:  Rudragouda Channappanavar; Craig Fett; Jincun Zhao; David K Meyerholz; Stanley Perlman
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.